Abstract
Menopause is associated with physical changes secondary to the loss of estrogen, including hot flushes, vaginal dryness, and bone demineralization that may have a profound impact on a woman’s quality of life. With the aging population, management of climacteric symptoms will become routine in gynecologic practice. The purpose of this chapter is to review the physiology of perimenopause, to discuss the appropriate use of hormonal therapy for management of menopausal symptoms, to discuss other benefits afforded from hormonal replacement therapy (HRT), and to discuss considerations for special populations when using hormonal therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed Al-Badr Ross S, Soroka D, Drutz HP. What is the available evidence for hormone replacement therapy in women with stress urinary incontinence? J Obstet Gynaecol Can. 2003;25:567–74.
American College of Obstetricians and Gynecologists. Committee opinion 556: postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism. Obstet Gynecol. 2013;121(4):887–90.
American College of Obstetricians and Gynecologists. Management of menopausal symptoms. Practice bulletin No. 141. Obstet Gynecol. 2014;123:202–16.
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2014;291(14):1701–12.
Burke WM, Orr J, Leitao M, et al. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol. 2014;134(2):393–402.
Cardozo L, Lose G, McClish D, et al. Estrogen treatment for symptoms of an overactive bladder, results of a meta-analysis. Int J Urogynaecol. 2001;12:V.
Cody JD, Richardson K, Moehrer B, et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009;4:CD001405.
Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–8.
Eriksen PS, Rasmussen H. Low dose 17b-oestradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynaecol Reprod Biol. 1992;44:137–44.
Fritz MA, Speroff L. Clinical gynecologic endocrinology and infertility. Philadelphia: Lippincott Williams & Wilkins; 2011.
Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol. 2000;152:463–73.
González M, Viáfara G, Caba F, Molina E. Sexual function, menopause and hormone replacement therapy (HRT). Maturitas. 2004;48(4):411–20.
Hickey M, Saunders CM, Stuckey BG. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol. 2005;6:687–95.
Kenemans P, Bundred NJ, Foidart JM, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol. 2009;10(2):135–46.
Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci. 1990;592:52–86. 123.
Lindsay R, Gallagher J, Kagan R, Pickar J, Constantine G. Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril. 2009;92(3):1045–52.
Martin K, Barbieri R. Treatment of menopausal symptoms with hormone therapy. 2014; Available from: www.uptodate.com
Menon KV, Angulo P, Boe GM, Lindor KD. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis. Am J Gastroenterol. 2003;98(4):889–92.
Rinaldi M, Cagnacci A, Pansini FE, De aloysio D, Sgarabotto MP, Bacchi-modena A. Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis. Menopause. 2005;12(5):619–22.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
Sator PG, Sator MO, Schmidt JB, et al. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric. 2007;10(4):320–34.
Shim SH, Lee SJ, Kim SN. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis. Eur J Cancer. 2014;50(9):1628–37.
Versi E, Cardozo LD. Oestrogens and lower urinary tract function. In: Studd JWW, Whitehead MI, editors. The menopause. Oxford: Blackwell; 1988. p. 76–84.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Barenberg, B.J., Pickett, S.D. (2017). Menopausal Hormone Therapy. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17798-4_48
Download citation
DOI: https://doi.org/10.1007/978-3-319-17798-4_48
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17797-7
Online ISBN: 978-3-319-17798-4
eBook Packages: MedicineReference Module Medicine